The solution should be clear when fully dissolved
51-OR: a phase 2, randomized, double-blind, placebo-controlled, dose-finding study of BI 456906 in people with overweight/obesity
BioWorld - Tuesday, July 28, 2026 See today's BioWorld Home $170M banked, Bioage phase II to test GLP-1/apelin combo To read the full story, subscribe or sign in
Camurus has the option to collect up to USD 290 million in upfront, development, and regulatory milestone payments, as well as USD 580 million in sales-based milestone payments and tiered mid-single digit royalties on worldwide net product sales
Albiglutide was less effective in activating the GLP-1R compared to exendin-4 in an in vitro study of a BHK cell line expressing the rat GLP-1R (92)